Ryan S. Medicines for migraine. Arch Dis Child Educ Pract Ed. 2007;92:ep50-ep55.
Eccleston C, Palermo TM, de C Williams AC, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2014;(5):CD003968.
Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016;(4):CD005220.
1. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629-808.
2. Ryan S. Medicines for migraine. Arch Dis Child Educ Pract Ed. 2007;92:ep50-ep55.
4. Migraine. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson textbook of pediatrics. 16th ed. Philadelphia, PA: Saunders; 2000:1832-1834.
5. Stewart WF, Linet MS, Celentano DD, et al. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991 Nov 15;134(10):1111-20.
6. Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States. JAMA. 1992;267:64-69.
7. Mortimer MJ, Kay J, Gawkrodger DJ, et al. The prevalence of headache and migraine in atopic children: an epidemiological study in general practice. Headache. 1993;33:427-431.
8. Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache. 1994;34:319-328.
9. Bille B. Migraine in schoolchildren. Acta Paediatr Suppl. 1962;136:1-151.
10. Deubner DC. An epidemiologic study of migraine and headache in 10-20 year olds. Headache. 1977;17:173-180.
11. Evers S. Drug treatment of migraine in children. A comparative review. Paediatr Drugs 1999;1:7-18.
12. Linet MS, Stewart WF, Celentano DD, et al. An epidemiologic study of headache among adolescents and young adults. JAMA. 1989;261:2211-2216.
13. Barnes N, Millman G, James E. Migraine headache in children. Clin Evid. 2006;15:469-475.
14. Bussone G. Pathophysiology of migraine. Neurol Sci. 2004;25 Suppl 3:S239-S241.
15. Ferrari MD. Migraine. Lancet. 1998;351;1043-1051.
16. Stewart WF, Staffa J, Lipton RB, et al. Familial risk of migraine: a population-based study. Ann Neurol. 1997 Feb;41(2):166-72.
17. Rothner AD. Childhood migraine: clinical features, classifications and diagnostic criteria. In: Abu-Arefeh I, ed. Childhood headache. London: MacKeith Press; 2002:54-65.
18. Hamalainen ML. Medical and dietary management of headache and migraine. In: Abu-Arefeh I, ed. Childhood headache. London: MacKeith Press; 2002:136-48.
19. Passchier J, Orlebeke JF. Headaches and stress in schoolchildren: an epidemiological study. Cephalalgia. 1985 Sep;5(3):167-76.
20. Amery WK, Vandenbergh V. What can precipitating factors teach us about the pathogenesis of migraine? Headache. 1987 Mar;27(3):146-50.
21. Barnes NP, Jayawant S. Migraine. Arch Dis Child Educ Pract Ed. 2005;90:ep53-ep57.
22. Wilne S, Koller K, Collier J, et al. The diagnosis of brain tumours in children: a guideline to assist healthcare professionals in the assessment of children who may have a brain tumour. Arch Dis Child. 2010 Jul;95(7):534-9.
23. Bonfert M, Straube A, Schroeder AS, et al. Primary headache in children and adolescents: update on pharmacotherapy of migraine and tension-type headache. Neuropediatrics. 2013 Feb;44(1):3-19.
24. Eccleston C, Palermo TM, de C Williams AC, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2014;(5):CD003968.
25. Bruijn J, Locher H, Passchier J, et al. Psychopathology in children and adolescents with migraine in clinical studies: a systematic review. Pediatrics. 2010 Aug;126(2):323-32.
26. Silver S, Gano D, Gerretsen P. Acute treatment of paediatric migraine: a meta-analysis of efficacy. J Paediatr Child Health. 2008 Jan;44(1-2):3-9.
27. Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016;(4):CD005220.
28. US Food and Drug Administration. FDA drug safety communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. April 2017 [internet publication].
29. Medicines and Healthcare Products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Drug Safety Update. 2013 June;6(11):S1.
30. European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. June 2013 [internet publication].
31. Brenner M, Lewis D. The treatment of migraine headaches in children and adolescents. J Pediatr Pharmacol Ther. 2008 Jan;13(1):17-24.
32. Damen L, Bruijn JK, Verhagen AP, et al. Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics. 2005 Aug;116(2):e295-302.
33. Eiland LS, Hunt MO. The use of triptans for pediatric migraines. Paediatr Drugs. 2010 Dec 1;12(6):379-89.
34. Lewis DW, Winner P, Hershey AD, et al; Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007 Aug;120(2):390-6.
35. Winner P, Lewis D, Visser WH, et al; Rizatriptan Adolescent Study Group. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache. 2002 Jan;42(1):49-55.
36. Bailey B, McManus BC. Treatment of children with migraine in the emergency department: a qualitative systematic review. Pediatr Emerg Care. 2008 May;24(5):321-30.
37. Ho TW, Pearlman E, Lewis D, et al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 2012 Jul;32(10):750-65.
38. Linder SL, Mathew NT, Cady RK, et al. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache. 2008 Oct;48(9):1326-36.
39. Charles JA. Almotriptan in the acute treatment of migraine in patients 11-17 years old: an open-label pilot study of efficacy and safety. J Headache Pain. 2006 Apr;7(2):95-7.
40. Berenson F, Vasconcellos E, Pakalnis A, et al. Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents. Headache. 2010 May;50(5):795-807.
41. Derosier FJ, Lewis D, Hershey AD, et al. Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine. Pediatrics. 2012 Jun;129(6):e1411-20.
42. Eiland LS, Jenkins LS, Durham SH. Pediatric migraine: pharmacologic agents for prophylaxis. Ann Pharmacother. 2007 Jul;41(7):1181-90.
43. El-Chammas K, Keyes J, Thompson N, et al. Pharmacologic treatment of pediatric headaches: a meta-analysis. JAMA Pediatr. 2013 Mar 1;167(3):250-8.
44. European Medicines Agency. New measures to avoid valproate exposure in pregnancy endorsed. EMA/145600/2018. March 2018 [internet publication].
45. Sorge F, Marano E. Flunarizine v. placebo in childhood migraine. A double-blind study. Cephalalgia. 1985;5(suppl 2):145-148.
46. Sorge F, De Simone R, Marano E, et al. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia. 1988;8:1-6.
47. Pearce JM. Migraine. In: Weatherall DJ, Ledingham JG, Warrell DA, eds. Oxford textbook of medicine. Oxford: Oxford University Press; 1996:4024-4026.
48. McGrath PJ, Humphreys P, Keene D, et al. The efficacy of a self-administered treatment for adolescent migraine. Pain. 1992;49:321-324.
49. Blau JN, Thavapalan M. Preventing migraine: a study of precipitating factors. Headache. 1988;28:481-483.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台